News

Ask the Doctor: How do physicians determine when follicular lymphoma has transformed to DLBCL? What kind of tests or symptoms help doctors monitor this?

Transformed lymphoma occurs when an indolent lymphoma turns into a more aggressive one. A transformation occurs when genetic changes in the indolent lymphoma cells cause them to begin growing faster and behaving more aggressively. Lymphoma Research Foundation Grantee Raphael Eric…

LRF Honors Michael E. Williams, MD with Mantle Cell Lymphoma Leadership Award

World-renowned hematologist/oncologist receives inaugural award for outstanding commitment in the field of mantle cell lymphoma research and patient care.

Ask the Doctor: What is the current efficacy of oral therapies for marginal zone lymphoma?

There are several chemotherapy and targeted anticancer drugs approved or under investigation for the treatment of lymphoma. Unlike traditional chemotherapy that is administered intravenously (IV) in a hospital or clinic, oral therapies are administered via a pill, taken at home…

Lymphoma Research Foundation Funds 29 New Grants Investigating Lymphoma and Chronic Lymphocytic Leukemia, Introduces Expanded Research Program and Health Equity Initiative

Investment supports early-career scientists dedicated to developing patient therapies and lymphoma cures.

Lymphoma Research Foundation Unites Lymphoma Community Nationwide Through Lymphoma Walk Program, Walk On! America

Thousands to Raise Awareness and Funds through Virtual Celebration and Socially Distanced Neighborhood Walks The Lymphoma Research Foundation (LRF) will offer Walk On! America, a twist on its Spring 2021 Team LRF Lymphoma Walks to bring the lymphoma community together safely in the time of COVID-19. Lymphoma…

U.S. Food and Drug Administration Approves CAR T Cell Therapy for Follicular Lymphoma

Axicabtagene ciloeucel has been approved for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL).

Best Shot: A Story of Hope

When Chris Gorelik received news that his central nervous system lymphoma would leave him with months to live, he sought a second opinion and took a chance on a new treatment protocol — to give him a fighting chance to see his children grow up.

Read the Latest Issue of Pulse: Winter 2021

Pulse is a publication of the Lymphoma Research Foundation, providing the latest updates on the Foundation and its focus on lymphoma and chronic lymphocytic leukemia (CLL) research, awareness and education.

The Ripple Effect in Lymphoma Research

LRF Scientific Advisory Board (SAB) member and grantee Michael Williams, MD, of the University of Virginia School of Medicine, sees lymphoma research as having a ripple effect. A lymphoma researcher has a much larger impact on the lives of those touched by this disease.

Updates from the 2020 American Society of Hematology Annual Meeting

Widely regarded as the premier event in malignant and non-malignant hematology, the ASH Meeting provided a critical forum for leading hematologists/ oncologists to present their findings to over 20,000 of their peers.

Subscribe to Our Emails. Get lymphoma and CLL resources and updates.